Aims and Objectives. To review the experience of a nurse-led colorectal cancer follow-up clinic in a tertiary referral colorectal cancer centre. Methodology. Data from the nurse-led colorectal cancer follow-up clinic in our unit was prospectively maintained in a colorectal cancer database. Data was analysed from January 1, 2006 until the December 31, 2011. Results. 1125 patients were diagnosed with colorectal cancer, and referred to our unit as a tertiary centre for specialised colorectal cancer. Nine hundred and four patients had surgical resection of their colorectal cancer. Four hundred and seven patients were referred to the nurse-led colorectal cancer clinic for surveillance. The mean age of the patient cohort was 67 years (range 32–88) and 56% of patients were male. One hundred and seventeen patients were discharged to their general practitioner having been disease free after 5 years of followup. Fifty-four patients were diagnosed with either local or distant recurrence. Conclusion. A nurse-led colorectal cancer follow-up clinic is running according to strict follow-up protocols. This type of clinic significantly reduces the number of routine follow-up patients that have to be seen by the colorectal surgical consultant. 1. Introduction The treatment of cancer in Ireland has changed over the last 5 years, with the introduction of centres of excellence in the Irish health service under the guidance of the National Cancer Control Programme [1]. The end result is 8 tertiary referral centres which now deal with all rectal cancers in Ireland. Taken with advances in neoadjuvant and adjuvant treatments and minimally invasive surgical techniques, survival of patients has improved following surgery for colorectal cancer [2–5]. This has led to an increasing number of patients being treated in these centres and subsequently requiring surveillance for several years following their treatment. Followup for colorectal cancer patients following surgical resection of the primary tumour is the standard of care. It has been shown to be beneficial in terms of identifying potential patients with recurrence, either local or systemic, who might be candidates for either systemic chemotherapy and/or surgical resection of their recurrent disease [6–9]. The traditional model is that these patients would attend the consultant-led clinic and have their follow-up scans, tumour markers, and endoscopy arranged and the results checked at a subsequent visit. The increased concentration of the treatment of colorectal cancer in a smaller number of centres in Ireland has led to an
References
[1]
“The National colorectal screening programme,” 2011, http://www.cancerscreening.ie/publications/Colorectal_Peer_Review_Report_Rev_2.pdf.
[2]
J. K. Lee, C. P. Delaney, and J. M. Lipman, “Current state of the art in laparoscopic colorectal surgery for cancer: update on the multi-centric international trials,” Annals of Surgical Innovation and Research, vol. 6, no. 1, p. 5, 2012.
[3]
W. Schwenk, O. Haase, J. Neudecker, and J. M. Müller, “Short term benefits for laparoscopic colorectal resection,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003145, 2005.
[4]
M. Buunen, R. Veldkamp, W. C. Hop, et al., “Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomized clinical trial,” The Lancet Oncology, vol. 10, no. 1, pp. 44–52, 2009.
[5]
P. Ragnhammar, L. Hafstr？m, P. Nygren, and B. Glimelius, “A systematic overview of chemotherapy effects in colorectal cancer,” Acta Oncologica, vol. 40, no. 2-3, pp. 282–308, 2001.
[6]
V. L. Tsikitis, K. Malireddy, E. A. Green et al., “Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial,” Journal of Clinical Oncology, vol. 27, no. 22, pp. 3671–3676, 2009.
[7]
D. Couch, N. Bullen, S. Ward-Booth, and C. Adams, “What interval between colorectal cancer first resection and surveillance colonoscopy? An audit of practice and yield,” Colorectal Disease, vol. 15, no. 3, pp. 317–322, 2012.
[8]
S. J. Winawer, A. G. Zauber, R. H. Fletcher et al., “Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society,” Ca: A Cancer Journal for Clinicians, vol. 56, no. 3, pp. 143–159, 2006.
[9]
A. Ntinas, N. Zambas, S. Al Mogrambi et al., “Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers,” Techniques in Coloproctology, vol. 8, supplement 1, pp. S190–S192, 2004.
[10]
National Institute for Health and Clinical Excellence (NICE), “Colorectal cancer, the diagnosis and management,” 2011.
[11]
American Society of Clinical Oncology (ASCO), “Colorectal Cancer Surveillance,” 2005.
[12]
The National Cancer Registry Ireland, “Incidence, Mortality, Treatment and Survival,” 2011, http://www.ncri.ie/.
[13]
S. V. Bala, K. Samuelson, P. Hagell, et al., “The experience of care at nurse-led rheumatology clinics,” Musculoskeletal Care, vol. 10, no. 4, pp. 202–211, 2012.
[14]
A. Figueredo, R. B. Rumble, J. Maroun et al., “Follow-up of patients with curatively resected colorectal cancer: a practice guideline,” BMC Cancer, vol. 3, article 26, 2003.
[15]
A. G. Renehan, M. Egger, M. P. Saunders, and S. T. O'Dwyer, “Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials,” British Medical Journal, vol. 324, no. 7341, pp. 813–816, 2002.
[16]
G. M. Jeffery, B. E. Hickey, and P. Hider, “Follow-up strategies for patients treated for non-metastatic colorectal cancer,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD002200, 2002.
[17]
A. J. Haddad, M. Bani Hani, T. M. Pawlik, and S. C. Cunningham, “Colorectal liver metastases,” International Journal of Surgical Oncology, vol. 2011, Article ID 285840, 12 pages, 2011.
[18]
A. M. Stiggelbout, J. C. de Haes, R. Vree et al., “Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up,” British Journal of Cancer, vol. 75, pp. 914–920, 1997.
[19]
A. G. Renehan, M. Egger, M. P. Saunders, and S. T. O'Dwyer, “Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis,” British Journal of Cancer, vol. 92, no. 3, pp. 430–433, 2005.
[20]
S. Faithfull, J. Corner, L. Meyer, R. Huddart, and D. Dearnaley, “Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy,” British Journal of Cancer, vol. 85, no. 12, pp. 1853–1864, 2001.
[21]
A. W. A. Kamps, R. J. Roorda, J. L. L. Kimpen, A. W. Overgoor-van de Groes, L. C. J. A. M. van Helsdingen, and P. L. P. Brand, “Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs,” European Respiratory Journal, vol. 23, no. 2, pp. 304–309, 2004.
[22]
G. Knowles, L. Sherwood, M. G. Dunlop et al., “Developing and piloting a nurse-led model of follow-up in the multidisciplinary management of colorectal cancer,” European Journal of Oncology Nursing, vol. 11, no. 3, pp. 212–223, 2007.
